1. Adoptive T-Cell Therapy of Melanoma Using Designer T-Cell Receptors

   • Kim Margolin

   Clinical Trial Report 20 September 2011 Pages: 427 - 429

2. Treatment of Advanced Melanoma with Immunological Checkpoint Block

   • Kim Margolin

   Clinical Trial Report 22 September 2011 Pages: 430 - 432

3. What is the Role of Chemotherapy in Endometrial Cancer?

   • Thomas Hogberg

   Gynecologic Cancers (Jonathan A. Ledermann, Section Editor) 27 August 2011 Pages: 433 - 441

4. PARP Inhibitors in BRCA Gene-Mutated Ovarian Cancer and Beyond

   • Susana Banerjee
   • Stan Kaye

   Gynecologic Cancers (Jonathan A. Ledermann, Section Editor) 14 September 2011 Pages: 442 - 449

   

5. Anti-angiogenic Agents in Ovarian Cancer: Dawn of a New Era?

   • Joyce Liu
   • Ursula A. Matulonis

   Gynecologic Cancers (Jonathan A. Ledermann, Section Editor) 13 October 2011 Pages: 450 - 458

6. Recurrent Ovarian Cancer: When and How to Treat

   • Marcia Hall
   • Gordon Rustin

   Gynecologic Cancers (Jonathan A. Ledermann, Section Editor) 03 November 2011 Pages: 459 - 471

7. The Role of Radiotherapy in Endometrial Cancer: Current Evidence and Trends

   • Carien L. Creutzberg
   • Remi A. Nout

   Gynecologic Cancers (Jonathan A. Ledermann, Section Editor) Open access 16 August 2011 Pages: 472 - 478

8. The “SWOT” of BRAF Inhibition in Melanoma: RAF Inhibitors, MEK Inhibitors or Both?

   • Moriah H. Nissan
   • David B. Solit

   Melanoma (Kim A. Margolin, Section Editor) 14 October 2011 Pages: 479 - 487

   

9. Immunobiology of Merkel Cell Carcinoma: Implications for Immunotherapy of a Polyomavirus-Associated Cancer

   • Shailender Bhatia
   • Olga Afanasiev
   • Paul Nghiem

   Melanoma (Kim Margolin, Section Editor) 28 September 2011 Pages: 488 - 497